For research use only. We do not sell to patients.
CCG215022
CAS No. : 1813527-81-9
Biological Activity：CCG215022 is a G protein-coupled receptor kinases (GRKs) inhibitor with IC50s of 0.15±0.07 μM, 0.38±0.06 μM and 3.9±1 μM for GRK2, GRK5 and GRK1, respectively.
Research Area：Cancer
Targets：PKA
Related Screening Libraries:Bioactive Compound Library Plus;Kinase Inhibitor Library;Stem Cell Signaling Compound Library;Anti-Cancer Compound Library;Anti-Aging Compound Library;Anti-Prostate Cancer Compound Library;
Related Small Molecules:PKI 14-22 amide,myristoylated TFA;Staurosporine;Malantide;DS89002333;Rp-8-CPT-cAMPS sodium;PF-4950834;Warangalone;STAD 2;AT13148;KT5720;8-Bromo-cAMP sodium salt;Bilobetin;Jaspamycin;UCN-02;H-8 dihydrochloride;AT7867;H-9 Dihydrochloride;Fasudil;Sp-cAMPS sodium salt;PKI(5-22)amide;8-pCPT-2′-O-Me-cAMP-AM;Metadoxine;Kemptide;H-89;Bucladesine sodium
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
